Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
June 1, 2020
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity
Andrew Bosworth, Celina Whalley, Charlie Poxon, et al.
The Lancet. Diabetes & Endocrinology
|
January 23, 2026
Feasibility of general population screening for type 1 diabetes in the UK: the ELSA study
Lauren M Quinn, Josephine Elliott, Theodora Papanikolaou, et al.
Science Advances
|
June 25, 2025
Stalling of the endometrial decidual reaction determines the recurrence risk of miscarriage
Joanne Muter, Chow-Seng Kong, Mireia Taus Nebot, et al.
The Journal of Allergy and Clinical Immunology
|
November 15, 2021
Treatment of chronic or relapsing COVID-19 in immunodeficiency
Li-An K Brown, Ed Moran, Anna Goodman, et al.
Journal of Hematology & Oncology
|
January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
Helen Parry, Graham McIlroy, Rachel Bruton, et al.
Plos Medicine
|
January 31, 2023
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
Lance Turtle, Mathew Thorpe, Thomas M Drake, et al.
Iscience
|
October 11, 2021
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery
Eleni Syrimi, Eanna Fennell, Alex Richter, et al.
Elife
|
September 29, 2021
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
Helen Parry, Gokhan Tut, Rachel Bruton, et al.
The Journal of Infection
|
January 12, 2022
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
Sian Faustini, Adrian Shields, Gemma Banham, et al.
Cancer Cell
|
May 19, 2022
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
Helen Parry, Rachel Bruton, Thomas Roberts, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
June 1, 2020
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity
Andrew Bosworth, Celina Whalley, Charlie Poxon, et al.
The Lancet. Diabetes & Endocrinology
|
January 23, 2026
Feasibility of general population screening for type 1 diabetes in the UK: the ELSA study
Lauren M Quinn, Josephine Elliott, Theodora Papanikolaou, et al.
Science Advances
|
June 25, 2025
Stalling of the endometrial decidual reaction determines the recurrence risk of miscarriage
Joanne Muter, Chow-Seng Kong, Mireia Taus Nebot, et al.
The Journal of Allergy and Clinical Immunology
|
November 15, 2021
Treatment of chronic or relapsing COVID-19 in immunodeficiency
Li-An K Brown, Ed Moran, Anna Goodman, et al.
Journal of Hematology & Oncology
|
January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
Helen Parry, Graham McIlroy, Rachel Bruton, et al.
Plos Medicine
|
January 31, 2023
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
Lance Turtle, Mathew Thorpe, Thomas M Drake, et al.
Iscience
|
October 11, 2021
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery
Eleni Syrimi, Eanna Fennell, Alex Richter, et al.
Elife
|
September 29, 2021
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
Helen Parry, Gokhan Tut, Rachel Bruton, et al.
The Journal of Infection
|
January 12, 2022
Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals
Sian Faustini, Adrian Shields, Gemma Banham, et al.
Cancer Cell
|
May 19, 2022
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
Helen Parry, Rachel Bruton, Thomas Roberts, et al.
Page
of 11